Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3691 AL 3705

Calcium signaling in Alzheimer's disease & therapies

Tong BC, Wu AJ, Li M, Cheung KH.

Biochim Biophys Acta Mol Cell Res. 2018 Nov;1865(11 Pt B):1745-1760. doi: 10.1016/j.bbamcr.2018.07.018. Epub 2018 Jul 29.

Derivation of induced pluripotent stem cells TUSMi006 from an 87-year old Chinese Han Alzheimer's disease patient carrying GRINB and SORL1 mutations

Wang Y, Yu H, Chen Y, Li G, Lei Y, Zhao J.

Stem Cell Res. 2018 Aug;31:127-130. doi: 10.1016/j.scr.2018.07.018. Epub 2018 Jul 25.

Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform

Kolaj I, Imindu Liyanage S, Weaver DF.

Neurochem Int. 2018 Nov;120:99-111. doi: 10.1016/j.neuint.2018.08.001. Epub 2018 Aug 8.

Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?

Dunys J, Valverde A, Checler F.

J Biol Chem. 2018 Oct 5;293(40):15419-15428. doi: 10.1074/jbc.R118.003999. Epub 2018 Aug 24.

Erythropoietin preparation drastically improved activities of daily living in a patient with severe dementia

Kumagai R, Koike M, Iwase Y, Ichimiya Y.

Psychiatry Clin Neurosci. 2018 Nov;72(11):849. doi: 10.1111/pcn.12777. Epub 2018 Oct 8.

Potential roles of brain barrier dysfunctions in the early stage of Alzheimer's disease

Jian WX, Zhang Z, Chu SF, Peng Y, Chen NH.

Brain Res Bull. 2018 Sep;142:360-367. doi: 10.1016/j.brainresbull.2018.08.012. Epub 2018 Aug 25.

Connecting the Dots: Linking the Biochemical to Morphological Transitions in Alzheimer's Disease

Baig AM.

ACS Chem Neurosci. 2019 Jan 16;10(1):21-24. doi: 10.1021/acschemneuro.8b00409. Epub 2018 Aug 30.

Long-term medical costs of Alzheimer's disease: matched cohort analysis

Sopina E, Spackman E, Martikainen J, Waldemar G, Sørensen J.

Eur J Health Econ. 2019 Apr;20(3):333-342. doi: 10.1007/s10198-018-1004-0. Epub 2018 Aug 31.

Exosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy

Iranifar E, Seresht BM, Momeni F, Fadaei E, Mehr MH, Ebrahimi Z, Rahmati M, Kharazinejad E, Mirzaei H.

J Cell Physiol. 2019 Mar;234(3):2296-2305. doi: 10.1002/jcp.27214. Epub 2018 Sep 7.

Effects of Androgens on the Amyloid-β Protein in Alzheimer's Disease

Lei Y, Renyuan Z.

Endocrinology. 2018 Dec 1;159(12):3885-3894. doi: 10.1210/en.2018-00660.

Effects of Tea Catechins on Alzheimer's Disease: Recent Updates and Perspectives

Ide K, Matsuoka N, Yamada H, Furushima D, Kawakami K.

Molecules. 2018 Sep 14;23(9):2357. doi: 10.3390/molecules23092357.

The leukotriene signaling pathway: a druggable target in Alzheimer's disease

Michael J, Marschallinger J, Aigner L.

Drug Discov Today. 2019 Feb;24(2):505-516. doi: 10.1016/j.drudis.2018.09.008. Epub 2018 Sep 18.

Role of Rab GTPases in Alzheimer's Disease

Zhang X, Huang TY, Yancey J, Luo H, Zhang YW.

ACS Chem Neurosci. 2019 Feb 20;10(2):828-838. doi: 10.1021/acschemneuro.8b00387. Epub 2018 Oct 11.

Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis

Doig AJ.

J Alzheimers Dis. 2018;66(1):25-36. doi: 10.3233/JAD-180583.

The Implications of Autophagy in Alzheimer's Disease

Hamano T, Hayashi K, Shirafuji N, Nakamoto Y.

Curr Alzheimer Res. 2018;15(14):1283-1296. doi: 10.2174/1567205015666181004143432.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias